40751-88-0 = 861306-04-9 反应条件:1.1 Catalysts: Palladium Solvents: Methanol; 3 H,40 °C 标题:Highly Selective One-Pot Synthesis Of H-Bonded Pentagon-Shaped Circular Aromatic Pentamers 作者:Qin,Bo; Et Al 参考文献:Chemical Communications (Cambridge 日期:2011 卷标:47(19) 页码:5419-5421]
40751-88-0 = 861306-04-9 反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol; 3 H,40 °C 标题:One-Pot Synthesis Of Hybrid Macrocyclic Pentamers With Variable Functionalizations Around The Periphery 作者:Qin,Bo; Et Al 参考文献:Organic Letters 日期:2011 卷标:13(9) 页码:2270-2273
专利号:US-7550510-B2 优先权日:2001-07-06 标 题 :Solid phase synthesis of arylretinamides 发明人:CURLEY JR ROBERT W; MERSHON SERENA M; BARNETT DEREK W; CLAGETT-DAME MARGARET; CHAPMAN JASON S 权利人:WISCONSIN ALUMNI RES FOUND 摘要:A solid phase synthetic method for preparing arylretinamides is provided. The method comprises reacting hexachloroacetone with a solvent-suspended resin-bound triphenylphosphine to provide a suspension comprising an activated chlorinating reagent; reacting retinoic acid with the activated chlorinating reagent to provide retinoyl chloride; adding pyridine and a select arylamine to the resulting mixture; and stirring the resulting mixture for a time and at a temperature sufficient for the select arylamine to react with the retinoyl chloride and provide the arylretinamide. Also provided, are select arylretinamides that can be prepared by the present method, and methods of using such arylretinamides to induce apoptosis in cancer cells.
专利号:US-2004102650-A1 优先权日:2001-07-06 标 题:Solid phase synthesis of arylretinamides
专利号:US-2003105164-A1 优先权日:2001-07-06 标 题 :Solid phase synthesis of arylretinamides
专利号:WO-03003987-A2 优先权日:2001-07-06 标题:Solid phase synthesis of arylretinamides
专利号:US-6696606-B2 优先权日:2001-07-06 标 题 :Solid phase synthesis of arylretinamides
专利号:SI-9300494-A 优先权日:1992-09-23 标 题:Process for preparing useful intermediates in the synthesis of imidazole compounds
参考文献:10.2165/11590190-000000000-00000 摘要:Geldenhuys WJ, Van der Schyf CJ. Role of serotonin in Alzheimer's disease: a new therapeutic target CNS Drugs. 2011 Sep 01;25(9):765–81. doi: 10.2165/11590190-000000000-00000.